The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 64.20
Ask: 65.80
Change: 0.60 (0.93%)
Spread: 1.60 (2.492%)
Open: 64.00
High: 65.00
Low: 64.00
Prev. Close: 64.40
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

16 Nov 2022 07:00

RNS Number : 5282G
IDOX PLC
16 November 2022
 

16 November 2022

Idox plc

('Idox', the 'Group' or the 'Company')

Year End Trading Update

A resilient performance

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset intensive sectors, today issues a trading update for its financial year ended 31 October 2022 ('FY22').

 

 

Group trading performance

 

We are pleased to report Idox has delivered a resilient performance for FY22 against a backdrop of economic uncertainty. We have continued to make progress towards a number of our medium-term strategic goals, putting the Group on a strong footing for the future.

 

Our focus on winning and retaining long-term recurring revenue contracts with high quality customers has resulted in record full year order intake in excess of c. £74m, up 19% on FY21, providing good visibility into FY23.

 

The Board expects to report (subject to audit) a c. 15% increase in full year adjusted EBITDA to c. £22.5m, in line with management's expectations. Revenue is expected to be up 6% to c. £66m, and recurring revenue is anticipated to be up c. 12% over the period to c. £40.5m. As a result, the Group expects to deliver an improved adjusted EBITDA margin of c. 34% (FY21: 31%).

 

The Group's net debt at year-end was £6.7m, a reduction since 31 October 2021 (£8.1m net debt). The Group continues to maintain significant balance sheet flexibility and strength, including a £35m revolving credit facility and a £10m accordion.

 

As reported in early October, Idox acquired Landhawk, a land mapping and GIS data business, for £1.5m, including an initial cash consideration of £1.1m. Landhawk further strengthens the Group's GIS capabilities following the acquisitions of Aligned Assets, thinkWhere and exeGesIS in FY21. We continue to pursue a number of acquisition opportunities but remain focussed on ensuring strategic alignment whilst maintaining a disciplined approach to valuations.

 

We have started FY23 with strong recurring revenue and good levels of contract renewals, a solid order book and a healthy pipeline. As a result, our expectations for FY23 remain unchanged, albeit we remain cognisant of the current economic environment.

 

 

David Meaden, Chief Executive Officer of Idox commented:

 

"We have laid the foundations for sustained success at Idox, and against a challenging macro-economic backdrop, we have delivered a robust set of results.

With recurring revenue and order intake up, we are well positioned to continue our success over the coming years, supported by a strong balance sheet.

 

Pleasingly, we have seen significant success in areas of strategic focus, notably with Idox Cloud where we have seen 15 new sales during the period, which bodes well for our future performance.

 The integration of recent acquisitions into the Group has progressed well and we have made several adjustments to our operating business, building capacity for future growth. I am pleased that our leadership development programme has ensured that all new senior appointees have been internal candidates.

 

We have a strong balance sheet position, leaving us well placed for an accretive buy and build programme. This, alongside our accelerating organic growth, will create significant value for shareholders and wider stakeholders going forward."

 

 

 

 

 

 

Notice of results

 

The Group expects to report its FY22 results in late January 2023. Management intends to host a results webinar on the day. Please contact MHP Communications to register your interest.

 

 

Definitions

 

Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

 

Net debt is defined as the aggregation of cash, bank borrowings and long-term bond.

 

 

For further information please contact:

 

Idox plc

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive Officer

Anoop Kang, Chief Financial Officer

 

+44 (0) 870 333 7101

investorrelations@idoxgroup.com

Peel Hunt LLP (NOMAD and Broker)

Paul Gillam

Michael Burke

James Smith

 

+44 (0) 20 7418 8900

MHP Communications

Reg Hoare

Ollie Hoare

Matthew Taylor

 

+ 44 (0) 20 3128 8276

idox@mhpc.com

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFELLFLFLLFBK
Date   Source Headline
14th Jan 20141:43 pmRNSIssue of Equity
8th Jan 20147:00 amRNSFinal Results
16th Dec 20137:00 amRNSEIM Contract Win
9th Dec 20137:00 amRNSChange of Adviser
28th Nov 20137:00 amRNSEIM Contract Win
7th Nov 20134:51 pmRNSHolding(s) in Company
4th Nov 201311:30 amRNSTrading Update
28th Oct 20134:31 pmRNSAdditional Listing
4th Oct 20131:47 pmRNSHolding(s) in Company
17th Sep 201312:30 pmRNSHolding(s) in Company
12th Sep 20137:00 amRNSContract Win
5th Sep 20134:46 pmRNSHolding(s) in Company
19th Aug 20133:40 pmRNSAdditional Listing
14th Aug 20137:00 amRNSDirectorate Change
22nd Jul 20137:00 amRNSDirector/PDMR Shareholding
1st Jul 20132:48 pmRNSCompletion of Disposal
1st Jul 20132:28 pmRNSCompletion of Acquisition of TFPL Limited
25th Jun 20137:00 amRNSAcquisition of TFPL Limited
25th Jun 20137:00 amRNSInterim Results
17th Jun 20138:06 amRNSHolding(s) in Company
14th Jun 20133:48 pmRNSHolding(s) in Company
11th Jun 20137:00 amRNSNon Executive Director Appointment
31st May 201311:31 amRNSHolding(s) in Company
30th May 201311:41 amRNSHolding(s) in Company
29th May 20137:00 amRNSTrading Statement
11th Apr 20137:00 amRNSAcquisition
11th Mar 20135:23 pmRNSDirector/PDMR Shareholding
28th Feb 20131:42 pmRNSAGM resolutions passed
28th Feb 20137:00 amRNSAGM Statement
11th Feb 20137:00 amRNSDirectorate Change
5th Feb 20137:00 amRNSAnnual Report & Accounts and Notice of AGM
21st Jan 20135:17 pmRNSHolding(s) in Company
8th Jan 20132:56 pmRNSFinal Divident Payment Date
7th Jan 20131:17 pmRNSHolding(s) in Company
20th Dec 201211:15 amRNSHolding(s) in Company
12th Dec 20127:00 amRNSFinal Results
3rd Dec 20121:31 pmRNSHolding(s) in Company
29th Nov 20122:32 pmRNSHolding(s) in Company
23rd Nov 201211:55 amRNSHolding(s) in Company
21st Nov 20125:24 pmRNSHolding(s) in Company
21st Nov 20122:23 pmRNSHolding(s) in Company
12th Nov 20127:00 amRNSTrading Update
19th Oct 20127:00 amRNSAcquisition
10th Oct 20128:46 amRNSNon-Executive Director Appointment
8th Oct 20127:00 amRNSLong Term Management Incentive Plan
13th Sep 201211:53 amRNSHolding(s) in Company
11th Sep 201212:36 pmRNSHolding(s) in Company
4th Sep 20125:54 pmRNSHolding(s) in Company
30th Aug 201212:48 pmRNSHolding(s) in Company
14th Aug 20129:38 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.